MDM2 Inhibitors
Learn MoreGlycolysis inhibitors are powerful tools in the field of metabolic research that target a key pathway involved in cellular energy production Glycolysis is the process by which glucose is converted into energy-rich molecules called ATP These inhibitors work by selectively blocking enzymes involved in glycolytic metabolism effectively disrupting the energy production process By inhibiting glycolysis these compounds hold promise for the development of novel treatments for metabolic disorders and cancer where dysregulation of glycolysis is often observed Our comprehensive range of glycolysis inhibitors provides researchers with the tools they need to study and manipulate cellular energy metabolism
Catalog Number | Chemical Name | CAS # | Price |
---|---|---|---|
EI-0041 | 2-Deoxy-D-Glucose | 154-17-6 | Online Inquiry |
EI-0047 | 3-Bromopyruvic acid | 1113-59-3 | Online Inquiry |
EI-0067 | 6-Aminonicotinamide | 329-89-5 | Online Inquiry |
EI-1362 | Lonidamine | 50264-69-2 | Online Inquiry |
EI-1662 | Oxythiamine Chloride Hydrochloride | 614-05-1 | Online Inquiry |
EI-2004 | Shikonin | 517-89-5 | Online Inquiry |
Glycolysis inhibitors have a wide range of applications in both research and medicine In the field of research these inhibitors are commonly used to study the role of glycolysis in various biological processes By blocking specific enzymes involved in glycolysis scientists can gain insights into the metabolic pathways and their impact on cellular function This knowledge can help in the development of targeted therapies for diseases such as cancer and metabolic disorders
In medicine glycolysis inhibitors can be used as potential anti-cancer agents Cancer cells heavily rely on glycolysis for energy production and inhibiting this process can disrupt their growth and survival Inhibitors targeting glycolysis enzymes have shown promising results in preclinical studies and are being investigated as potential treatments for various types of cancer
Additionally glycolysis inhibitors can be used to control glucose metabolism in diabetes management By blocking specific steps in the glycolytic pathway these inhibitors can help regulate blood sugar levels and improve insulin sensitivity
Overall the use of glycolysis inhibitors in research and medicine offers opportunities for understanding cellular processes and developing innovative therapeutic approaches
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.